HSBC Holdings’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

HSBC Holdings’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-751,453	Closed	-$87M	–	2990
2023 Q3	$87M	Buy	751,453 +81,581	+12%	+$8.77M	0.09%	213
2023 Q2	$68.9M	Buy	669,872 +523,879	+359%	+$55.3M	0.07%	286
2023 Q1	$15.9M	Buy	145,993 +15,890	+12%	+$1.76M	0.02%	686
2022 Q4	$14.8M	Buy	130,103 +118,791	+1,050%	+$9.87M	0.02%	768
2022 Q3	$712K	Sell	11,312 -7,571	-40%	-$529K	﹤0.01%	2000
2022 Q2	$1.53M	Buy	18,883 +12,858	+213%	+$1.22M	﹤0.01%	1714
2022 Q1	$639K	Sell	6,025 -4,632	-43%	-$451K	﹤0.01%	2234
2021 Q4	$1.15M	Sell	10,657 -115	-1%	-$12.5K	﹤0.01%	1960
2021 Q3	$1.18M	Sell	10,772 -16,004	-60%	-$1.66M	﹤0.01%	1796
2021 Q2	$2.53M	Buy	26,776 +989	+4%	+$91K	﹤0.01%	1346
2021 Q1	$2.37M	Sell	25,787 -1,666	-6%	-$141K	﹤0.01%	1253
2020 Q4	$1.98M	Buy	27,453 +22,677	+475%	+$1.69M	﹤0.01%	1337
2020 Q3	$373K	Buy	+4,776	New	+$329K	﹤0.01%	2120
2020 Q1	–	Sell	-24,716	Closed	-$892K	–	3179
2019 Q4	$892K	Sell	24,716 -19,264	-44%	-$591K	﹤0.01%	1896
2019 Q3	$1.2M	Buy	+43,980	New	+$1.14M	﹤0.01%	1860
2019 Q2	–	Sell	-13,182	Closed	-$349K	–	2946
2019 Q1	$349K	Buy	+13,182	New	+$312K	﹤0.01%	2270
2017 Q1	–	Sell	-32,893	Closed	-$532K	–	2780
2016 Q4	$532K	Buy	+32,893	New	+$596K	﹤0.01%	1783
2015 Q3	–	Sell	-6,929	Closed	-$241K	–	2245
2015 Q2	$241K	Buy	+6,929	New	+$211K	﹤0.01%	1728

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.51B AUM 13.02% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

HSBC Holdings's HZNP Position: Q4 2023 in Review

HSBC Holdings sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 751,453 shares — an estimated $87M sold.

HSBC Holdings first reported a position in HZNP in Q2 2015 and held it in 18 quarters. The position peaked at $87M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

HSBC Holdings reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
HSBC Holdings sold 751,453 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $87M.
HSBC Holdings first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 18 quarters.
HSBC Holdings's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $87M in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on HSBC Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.